Themes in allergy

被引:8
作者
Bousquet, J [1 ]
Bieber, T [1 ]
Fokkens, W [1 ]
Humbert, M [1 ]
Kowalski, M [1 ]
Niggemann, B [1 ]
Simon, HU [1 ]
机构
[1] CHU Montpellier, Hop Arnaud Villeneuve, Clin Malad Resp, F-34295 Montpellier, France
关键词
D O I
10.1111/j.1398-9995.2006.01020.x
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:1 / 2
页数:2
相关论文
共 28 条
[1]   Standardization of food challenges in patients with immediate reactions to foods - position paper from the European Academy of Allergology and Clinical Immunology [J].
Bindslev-Jensen, C ;
Ballmer-Weber, BK ;
Bengtsson, U ;
Blanco, C ;
Ebner, C ;
Hourihane, J ;
Knulst, AC ;
Moneret-Vautrin, DA ;
Nekam, K ;
Niggemann, B ;
Osterballe, M ;
Ortolani, C ;
Ring, J ;
Schnopp, C ;
Werfel, T .
ALLERGY, 2004, 59 (07) :690-697
[2]  
Bousquet J, 2005, B WORLD HEALTH ORGAN, V83, P548
[3]  
Bousquet J, 2004, ALLERGY, V59, P373
[4]   Epigenetic inheritance of fetal genes in allergic asthma [J].
Bousquet, J ;
Jacot, W ;
Yssel, H ;
Vignola, AM ;
Humbert, M .
ALLERGY, 2004, 59 (02) :138-147
[5]   European Union meets the challenge of the growing importance of allergy and asthma in Europe [J].
Bousquet, J ;
Ansotegui, IJ ;
van Ree, R ;
Burney, PG ;
Zuberbier, T ;
van Cauwenberge, P .
ALLERGY, 2004, 59 (01) :1-4
[6]   Making sense of asthma genes [J].
Cookson, W ;
Moffatt, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (17) :1794-1796
[7]   EAACI position paper on rhinosinusitis and nasal polyps executive summary [J].
Fokkens, W ;
Lund, V ;
Bachert, C ;
Clement, P ;
Helllings, P ;
Holmstrom, M ;
Jones, N ;
Kalogjera, L ;
Kennedy, D ;
Kowalski, M ;
Malmberg, H ;
Mullol, J ;
Passali, D ;
Stammberger, H ;
Stierna, P .
ALLERGY, 2005, 60 (05) :583-601
[8]   Organization of secondary lymphoid tissue and local IgE formation to Staphylococcus aureus enterotoxins in nasal polyp tissue [J].
Gevaert, P ;
Holtappels, G ;
Johansson, SGO ;
Cuvelier, C ;
Cauwenberge, P ;
Bachert, C .
ALLERGY, 2005, 60 (01) :71-79
[9]   The SAFE project: 'plant food allergies: field to table strategies for reducing their incidence in Europe' an EC-funded study [J].
Hoffmann-Sommergruber, K .
ALLERGY, 2005, 60 (04) :436-442
[10]   Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment):: INNOVATE [J].
Humbert, M ;
Beasley, R ;
Ayres, J ;
Slavin, R ;
Hébert, J ;
Bousquet, J ;
Beeh, KM ;
Ramos, S ;
Canonica, GW ;
Hedgecock, S ;
Fox, H ;
Blogg, M ;
Surrey, K .
ALLERGY, 2005, 60 (03) :309-316